.Only 5 months after securing a $100 thousand IPO, Boundless Biography is actually already giving up...
.The initial stages of oncology R&D aren't short of intriguing brand new modalities, and also Hal...
.Psychopharmacology has actually taken three write-ups about midstage medical trial information exam...
.Avidity Biosciences pleased financiers along with phase 1/2 data in Duchenne muscular dystrophy (DM...
.Actinogen Medical's cortisol blocker has missed the key endpoint of a period 2 research in anxiety,...
.Antibody-drug conjugates (ADCs) have actually gone to the facility of many a billion-dollar biobuck...
.Property manager TPG, which has actually sustained biotechs including Sionna Therapies as well as S...
.Merck & Co.'s TIGIT program has actually experienced one more setback. Months after shuttering a...
.After a year defined by pipeline cuts, the shift of its chief executive officer as well as layoffs,...
.Cullinan Therapy was excited sufficient along with Port BioMed's bispecific immune activator that i...